Drug technology

<br />Scant funds: Kiran Mazumdar-Shaw of Biocon Ltd says large private sector funding for tech start-ups will remain tight for some time. Hemant Mishra / Mint<br />

PE firms pass up start-up pharma cos

1 min read . 16 Nov 2008